VFA
MDCO

Virtus Fund Advisers’s Medicines Co MDCO Stock Holding History

Virtus Fund Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$963K Buy
+35,217
New +$1.08M 0.01% 296
2014
Q3 		– Sell
-5,548
Closed -$161K – 2254
2014
Q2 		$161K Buy
+5,548
New +$148K ﹤0.01% 1077

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's MDCO Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Medicines Co (MDCO) in Q4 2017: 35,217 shares worth $963K. The stake represents 0.01% of the portfolio and ranks #296 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in MDCO as recently as Q2 2014.

Virtus Fund Advisers first reported a position in MDCO in Q2 2014 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold MDCO as of Q4 2017.

  • Virtus Fund Advisers held 35,217 shares of Medicines Co worth $963K as of Q4 2017.
  • Medicines Co was a new Virtus Fund Advisers position in Q4 2017.
  • Medicines Co made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #296 holding.
  • Virtus Fund Advisers first reported a position in Medicines Co in Q2 2014 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.